In this study, we discovered significant upregulation and activation of the YAP/TAZ pathway in trastuzumab-resistant HER2-positive cancer cells, as evidenced by the robust nuclear accumulation and activation of YAP. This evidence concerns the gene ERBB2 and cancer.